Silgan (NYSE:SLGN) Releases Earnings Results, Beats Estimates By $0.02 EPS

Silgan (NYSE:SLGN) released its quarterly earnings data on Wednesday. The industrial products company reported $0.98 EPS for the quarter, topping analysts’ consensus estimates of $0.96 by $0.02, Zacks reports. Silgan had a net margin of 4.05% and a return on equity of 16.74%. The company had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.62 billion. During the same period last year, the firm earned $1.01 EPS. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. Silgan updated its FY 2026 guidance to 3.730-3.930 EPS and its Q3 2026 guidance to 1.210-1.310 EPS.

Here are the key takeaways from Silgan’s conference call:

• 2026 guidance was reaffirmed: Silgan maintained its adjusted EPS outlook of $3.73–$3.93, free cash flow estimate of approximately $450 million, and low- to mid-single-digit adjusted EBIT growth expectations.
• Management expects stronger second-half performance, including third-quarter volume growth across all segments on a comparable basis. Metal Containers volumes are expected to grow low- to mid-single digits in the third quarter, supported by wet pet food growth and the timing of vegetable-container orders.
• Second-quarter sales rose 7% to approximately $1.6 billion, but adjusted EBIT declined 4% to $185 million and adjusted EPS fell to $0.98 from $1.01. Higher raw-material pass-throughs and favorable interest expense helped offset operational and corporate-cost pressures.
• Dispensing and Specialty Closures faced a 15% volume decline in Brazil, contributing to a 1% segment volume decline and an approximately $5 million impact from lower volume and mix. Management expects recovery to begin in the fourth quarter, with full recovery projected by 2027.
• Wet pet food volumes increased 7% year over year, while Custom Containers EBIT improved despite lower reported volumes due to footprint-optimization savings and favorable price-over-cost. Fine fragrance and healthcare products also remain key longer-term growth areas, with substantial 2027 healthcare and fragrance business already contractualized or in commercialization.

Silgan Trading Down 1.5%

SLGN traded down $0.63 during trading on Friday, reaching $40.43. 846,134 shares of the company’s stock were exchanged, compared to its average volume of 1,001,647. The company’s fifty day moving average price is $42.53 and its 200-day moving average price is $42.51. The company has a debt-to-equity ratio of 1.58, a quick ratio of 0.78 and a current ratio of 0.53. The firm has a market capitalization of $4.27 billion, a PE ratio of 15.84, a P/E/G ratio of 2.34 and a beta of 0.66. Silgan has a fifty-two week low of $35.68 and a fifty-two week high of $49.55.

Silgan Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were paid a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend was Monday, June 1st. Silgan’s payout ratio is 31.58%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. EverSource Wealth Advisors LLC raised its holdings in Silgan by 627.2% in the second quarter. EverSource Wealth Advisors LLC now owns 669 shares of the industrial products company’s stock worth $36,000 after purchasing an additional 577 shares during the period. Measured Wealth Private Client Group LLC bought a new stake in shares of Silgan in the third quarter worth about $33,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of Silgan during the 1st quarter valued at about $54,000. UMB Bank n.a. raised its holdings in Silgan by 2,609.1% during the 4th quarter. UMB Bank n.a. now owns 2,086 shares of the industrial products company’s stock worth $84,000 after buying an additional 2,009 shares during the period. Finally, Virtus Advisers LLC bought a new position in Silgan in the third quarter valued at approximately $137,000. Institutional investors own 70.25% of the company’s stock.

Analysts Set New Price Targets

SLGN has been the topic of a number of recent research reports. Bank of America lifted their price objective on Silgan from $53.00 to $58.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. UBS Group set a $47.00 target price on shares of Silgan and gave the company a “neutral” rating in a research note on Thursday. Citigroup reduced their price target on shares of Silgan from $56.00 to $54.00 and set a “buy” rating on the stock in a research report on Thursday, April 30th. Truist Financial dropped their price objective on shares of Silgan from $54.00 to $52.00 and set a “buy” rating for the company in a report on Thursday, April 30th. Finally, Wells Fargo & Company reaffirmed an “overweight” rating and set a $56.00 price target (up from $55.00) on shares of Silgan in a report on Thursday, April 30th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $53.30.

Silgan Company Profile

Silgan Holdings Inc (NYSE: SLGN) is a leading supplier of rigid packaging solutions for consumer goods manufacturers. The company’s core business activities center on the design, production and distribution of metal and plastic containers, closures and dispense systems. Silgan serves a broad array of end markets, including food and beverage, home and personal care, health care and industrial products, providing both standard and custom packaging formats.

Founded in 1987 and headquartered in Stamford, Connecticut, Silgan has grown organically and through strategic acquisitions to establish a global manufacturing footprint.